Marcelo Reyes-Eldblom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcelo Reyes-Eldblom has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abel Gomez-Caceres
Department of Physical Therapy, Faculty of Health Sciences, University of Malaga, 29071 Malaga, Spain
1 shared publication - Daniel Rosado-Velazquez
Department of Physical Therapy, Faculty of Health Sciences, University of Malaga, 29010 Malaga, Spain
1 shared publication - Francisco Moya Torrecilla
FML Emergency Medicine Department, Quirónsalud Málaga Hospital, 29004 Málaga, Spain
1 shared publication - Ivan Medina-Porqueres
Department of Physical Therapy, Faculty of Health Sciences, University of Málaga, Málaga, Spain
1 shared publication - Pablo Martin-Garcia
Onco-Hematology Unit, University Hospital Virgen de la Victoria, 29010 Malaga, Spain
1 shared publication - Rafael Mondragon-Cortes
Medical Services, Malaga Football Club, 29011 Malaga, Spain
1 shared publication
Latest Publications
- Open Access
- 26 April 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (5) , 963
Platelet-Rich Plasma Injections in Chronic Lateral Ankle Instability: A Case Series
The platelet-rich plasma (PRP) approach may be an effective treatment for joint and cartilage pathologies. However, the rationale for its effectiveness on joint instability is limited. This study aimed to assess the safety and effectiveness of PRP injections in patients with chronic lateral ankle instability (CLAI). This retrospective study was performed at a single-center outpatient clinic between January 2015 and February 2023 and included pre-intervention assessment and short-term follow-up. Patients were excluded if they had received previous surgical treatment or had constitutional hyperlaxity, systemic diseases, or grade II or III osteoarthritis. The clinical and functional evaluation consisted of the Karlsson score, the Cumberland Ankle Instability Tool (CAIT), Good’s grading system, the patient’s subjective satisfaction level, and the time required to return to exercise. The entire PRP therapy regime consisted of three PRP administrations at 7-day intervals and follow-up appointments. PRP was administered both intraarticularly and into talofibular ligaments. A total of 47 consecutive patients with CLAI were included, 11 were female (23.4%), with a mean age at intervention of 31.19 ± 9.74 years. A statistically significant improvement was found in the CAIT and Karlsson scores at 3 months (27.74 ± 1.68 and 96.45 ± 4.28, respectively) relative to the pre-intervention status (10.26 ± 4.33 and 42.26 ± 14.9, respectively, p < 0.000). The mean follow-up of patients with CLAI was 17.94 ± 3.25 weeks. This study represents successful short-term functional and clinical outcomes in patients with CLAI after PRP treatment, with no adverse effects. It demonstrates the feasibility of a randomized controlled trial to further assess this therapy.
- 26 April 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (5) , 963
Open AccessPlatelet-Rich Plasma Injections in Chronic Lateral Ankle Instability: A Case Series
The platelet-rich plasma (PRP) approach may be an effective treatment for joint and cartilage pathologies. However, the rationale for its effectiveness on joint instability is limited. This study aimed to assess the safety and effectiveness of PRP injections in patients with chronic lateral ankle instability (CLAI). This retrospective study was performed at a single-center outpatient clinic between January 2015 and February 2023 and included pre-intervention assessment and short-term follow-up. Patients were excluded if they had received previous surgical treatment or had constitutional hyperlaxity, systemic diseases, or grade II or III osteoarthritis. The clinical and functional evaluation consisted of the Karlsson score, the Cumberland Ankle Instability Tool (CAIT), Good’s grading system, the patient’s subjective satisfaction level, and the time required to return to exercise. The entire PRP therapy regime consisted of three PRP administrations at 7-day intervals and follow-up appointments. PRP was administered both intraarticularly and into talofibular ligaments. A total of 47 consecutive patients with CLAI were included, 11 were female (23.4%), with a mean age at intervention of 31.19 ± 9.74 years. A statistically significant improvement was found in the CAIT and Karlsson scores at 3 months (27.74 ± 1.68 and 96.45 ± 4.28, respectively) relative to the pre-intervention status (10.26 ± 4.33 and 42.26 ± 14.9, respectively, p < 0.000). The mean follow-up of patients with CLAI was 17.94 ± 3.25 weeks. This study represents successful short-term functional and clinical outcomes in patients with CLAI after PRP treatment, with no adverse effects. It demonstrates the feasibility of a randomized controlled trial to further assess this therapy.